Abstract: The present invention provides a composition for a medicinal or health effect of a treatment of liver fat and body fat, a reduction of blood pressure, an increase of the energy expenditure rate, a reduction of inflammatory C-reactive proteins and a reduction of plasma aminotransferase enzymes, comprising an effective amount of fucoxanthin alone or in combination with pomegranate seed oil, a pharmaceutically acceptable salt, a prodrug thereof, or a salt of the prodrug; and a method of using the same. The fucoxanthin may be used in pure form, or as a component of a brown marine vegetable extract.

Abstract: The present invention provides a composition for a medicinal or health effect of a treatment of liver fat and body fat, a reduction of blood pressure, an increase of the energy expenditure rate, a reduction of inflammatory C-reactive proteins and a reduction of plasma aminotransferase enzymes, comprising an effective amount of fucoxanthin alone or in combination with pomegranate seed oil, a pharmaceutically acceptable salt, a prodrug thereof, or a salt of the prodrug; and a method of using the same. The fucoxanthin may be used in pure form, or as a component of a brown marine vegetable extract.

Abstract: The present invention provides a composition for a medicinal or health effect of a treatment of liver fat and body fat, a reduction of blood pressure, an increase of the energy expenditure rate, a reduction of inflammatory C-reactive proteins and a reduction of plasma aminotransferase enzymes, comprising an effective amount of fucoxanthin alone or in combination with pomegranate seed oil, a pharmaceutically acceptable salt, a prodrug thereof, or a salt of the prodrug; and a method of using the same. The fucoxanthin may be used in pure form, or as a component of a brown marine vegetable extract.

Abstract: Methods for treating obesity, reducing total weight and reducing body fat mass by administering a composition comprising dihydroquercetins and root-derived aralosides A, B, C and D is disclosed.

Abstract: The present invention encompasses pharmaceutical compositions for the treatment of obesity. These compositions comprise dihydroquercetins (dihydroquercetin 3-rhamnoside and its aglycon dihydroquercetin) and the triterpene saponins known as aralosides or elatosides. The compositions of the present invention effectively promote total weight loss and body fat mass loss. Therefore, the present invention is also directed to methods for treating obesity, reducing total weight, and reducing body fat mass by administering the compositions of the invention. The invention also embraces methods for disrupting the perilipin shell of lipid droplets and stimulating the activity of hormone-sensitive lipase.

Abstract: Compounds and methods are provided for reducing myostatin concentration. The compounds include an extract of Cystoseira canariensis having at least one sulfated polysaccharide. Each of the at least one sulfated polysaccharides preferably has fewer than nine saccharide units. The compounds also may include fluorotannins, fluoroglucinols or both.

Abstract: A method is provided for processing Cystoseira canariensis. It includes contacting the Cystoseira canariensis with a solvent to extract a fraction comprising at least one sulfated polysaccharide. The method preferably is carried out as a multiple stage extraction. A method also is provided for producing Cystoseira canariensis. This method includes (a) obtaining a Cystoseira canariensis starting material, and (b) growing the Cystoseira canariensis starting material in a vessel containing a liquid growth medium comprising water to produce the Cystoseira canariensis. This method includes circulating a portion of the liquid growth medium within the vessel adjacent to the Cystoseira canariensis starting material.

Abstract: A novel and environmentally friendly method is disclosed for producing a purified extract from Ginkgo biloba leaves comprising the novel steps of differential centrifugation and extraction with supercritical CO.sub.2.